The UCSF Bixby Center's partnership with the University of Zimbabwe (UZ) recently joined a global research effort to develop a safe and effective vaccine to prevent HIV.
Previous research on migration and HIV in sub-Saharan Africa has primarily focused on male migrants' risk of HIV, despite the fact that equal or greater numbers of women are migrating in the region.
A large cluster randomized trial conducted by the UCSF Bixby Center examined if integrating family planning with HIV/AIDS services can help bridge this gap and increase the use of contraception among HIV-positive women and men.
A UCSF Bixby Center program in Zimbabwe recently received a seven-year grant for $70 million to further its groundbreaking HIV/AIDS treatment and prevention research efforts.